AstraZeneca closing U.S. plant, costing 180 jobs – FiercePharma Manufacturing
0
AstraZeneca ($AZN) has been fighting a losing legal battle to protect the patent on its asthma drug Pulmicort Respules, and a plant in Massachusetts will pay part of the price. The U.K. drugmaker says it will close the plant next year, putting 180 workers out of jobs.
Read more – FiercePharma Manufacturing